{
    "nctId": "NCT05326295",
    "briefTitle": "Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients",
    "officialTitle": "Surveillance of Circulating Tumor Cell Phenotype in Early Stage Breast Cancer Patients With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "iDFS",
    "eligibilityCriteria": "Inclusion Criteria\n\n* The age is more than 18 years old;\n* Pathology confirmed malignant breast tumor;\n* No clinical diagnosis of other malignancies, unstable complications or uncontrolled infection;\n* Life expectancy is greater than 6 month;\n* The main organ function is normal;\n* The subjects volunteered to participate in this study, signed informed consent, followed up with good compliance.\n\nExclusion Criteria\n\n* Patients who had suffered from other malignant tumors;\n* With uncontrolled bacterial, viral or fungal infections;\n* With physical or mental disorders\n* Without or limited civil capacity;\n* Infected with human immunodeficiency virus (HIV)\uff1b\n* Circumstances in which the investigator considers it inappropriate to participate in this study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}